| Application no. and date | 15750051.3 (espacenet) (Federated) (European Patent Register), 20150812 | | Patent/reg. no. and date | DK/EP 3180087, 20190313 | | Publication date | 20170621 | | Priority no. and date | GB 201414270, 20140812, GB 201422614, 20141218, GB 201507541, 20150501 | | EP pub. no. and date |
EP 3180087 20170621 | | Effective date | | | Applicant/owner | Alligator Bioscience AB, Medicon Village
223 81 Lund, SE | | Applicant ref. no. | P68010DK01 | | Inventor | ELLMARK, Peter, Alligator Bioscience
Medicon Village
233 81 Lund, SE,
NORLEN, Per, Alligator Bioscience
Medicon Village
233 81 Lund, SE,
VEITONMÄKI, Niina, Alligator Bioscience
Medicon Village
233 81 Lund, SE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | KOMBINATIONSTERAPIER MED ANTI CD40-ANTISTOFFER | | Int. application no. | EP2015068598 | | Int. publication no. | WO2016023960 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
